13. Major Suppliers and Customers (Details Narrative)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Supplies [Member] | Supplier 1 [Member]
Concentration risk	19.97%
Supplies [Member] | Supplier A [Member]
Concentration risk		21.96%
Supplies [Member] | Supplier B [Member]
Concentration risk		18.95%
Supplies [Member] | Supplier C [Member]
Concentration risk		18.54%
Sales Revenue, Net [Member] | Shandong Yibao Biologics [Member]
Concentration risk	42.76%	28.72%
Sales Revenue, Net [Member] | Anhui Xiancheng Import and Export Company [Member
Concentration risk	27.43%
Sales Revenue, Net [Member] | Ping Xiang Import and Export [Member]
Concentration risk	14.85%	15.46%
Sales Revenue, Net [Member] | Nanjing Hejian Biologics [Member]
Concentration risk		18.51%
Sales Revenue, Net [Member] | Jiangshan Huacheng Import and Export [Member]
Concentration risk		12.32%